Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University Hospital, 3401 N Broad Street, Philadelphia, PA, 19140, USA.
Respir Res. 2024 Feb 7;25(1):79. doi: 10.1186/s12931-024-02674-9.
The latest European Society of Cardiology and European Respiratory Society guidelines have changed the definition of both pre-capillary pulmonary hypertension (PH) and severe PH in chronic lung disease. The clinical significance of these new criteria are unclear among patients with chronic obstructive pulmonary disease (COPD)-PH. We aim to examine the clinical significance of the new PH definitions with regards to lung transplant waitlist mortality amongst patients with COPD-PH.
This was a retrospective cohort study of adult patients with COPD-PH listed for lung transplantation. Kaplan-Meier survival analyses were performed comparing patients with newly defined pre-capillary PH to those without pre-capillary PH and comparing patients with severe PH, defined as pulmonary vascular resistance (PVR) > 5 WU, to those without severe PH. Both mean pulmonary artery pressure (mPAP) and PVR were analyzed for potential cut-off points associated with increased waitlist mortality. Predictors of waitlist mortality were identified via Cox regression.
Among 6495 patients with COPD-PH listed for lung transplantation, pre-capillary PH was not associated with increased waitlist mortality (logrank p = 0.43), while severe PH was (logrank p < 0.001). Both severe PH (HR 1.79, 95% CI 1.22-2.60, p = 0.003) and PVR > 3.9 WU (HR 1.49, 95% CI 1.14-1.95, p = 0.004) were independently and significantly associated with increased waitlist mortality.
PVR may serve as a strong predictor of lung transplant waitlist mortality among patients with COPD-PH as compared to other pulmonary hemodynamic parameters when predicting transplant waitlist mortality.
欧洲心脏病学会和欧洲呼吸学会的最新指南改变了毛细血管前肺动脉高压(PH)和慢性肺部疾病中重度 PH 的定义。这些新标准在 COPD-PH 患者中的临床意义尚不清楚。我们旨在研究新的 PH 定义在 COPD-PH 患者肺移植等待名单死亡率方面的临床意义。
这是一项对 COPD-PH 患者进行肺移植的回顾性队列研究。通过 Kaplan-Meier 生存分析比较新定义的毛细血管前 PH 患者与无毛细血管前 PH 患者,比较肺动脉阻力(PVR)>5 WU 的重度 PH 患者与无重度 PH 患者。分析平均肺动脉压(mPAP)和 PVR 潜在的切点与增加等待名单死亡率的关系。通过 Cox 回归识别等待名单死亡率的预测因素。
在 6495 例 COPD-PH 患者中,毛细血管前 PH 与等待名单死亡率增加无关(logrank p=0.43),而重度 PH 则相关(logrank p<0.001)。重度 PH(HR 1.79,95%CI 1.22-2.60,p=0.003)和 PVR>3.9 WU(HR 1.49,95%CI 1.14-1.95,p=0.004)均独立且显著与等待名单死亡率增加相关。
与其他肺血流动力学参数相比,PVR 可能是 COPD-PH 患者肺移植等待名单死亡率的有力预测因素,在预测移植等待名单死亡率方面。